Dark Forest Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
+3,501
New +$1.07M 0.08% 436
2026
Q1
Sell
-20,131
Closed -$5.54M 1183
2025
Q4
$5.54M Buy
20,131
+19,028
+1,725% +$5.2M 0.25% 77
2025
Q3
$289K Buy
+1,103
New +$268K 0.01% 1036
2025
Q2
Sell
-2,950
Closed -$660K 1546
2025
Q1
$660K Buy
+2,950
New +$813K 0.03% 844
2024
Q4
Sell
-788
Closed -$237K 1315
2024
Q3
$237K Buy
+788
New +$241K 0.03% 788
2023
Q2
Sell
-19
Closed -$6.58K 1439
2023
Q1
$6.58K Buy
+19
New +$5.55K ﹤0.01% 1059
2022
Q4
Sell
-66
Closed -$16K 1523
2022
Q3
$16K Buy
+66
New +$20.1K ﹤0.01% 658
2022
Q1
Sell
-135
Closed -$63K 1813
2021
Q4
$63K Buy
+135
New +$58.1K 0.02% 420
2021
Q3
Sell
-831
Closed -$298K 1582
2021
Q2
$298K Buy
+831
New +$275K 0.13% 94

Other funds holding WST

Dark Forest Capital Management's WST Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 3,501 shares worth $1.26M. The stake represents 0.08% of the portfolio and ranks #436 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in WST as recently as Q4 2025.

Dark Forest Capital Management first reported a position in WST in Q2 2021 and has held it in 9 quarters since. The position peaked at $5.54M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Dark Forest Capital Management held 3,501 shares of West Pharmaceutical worth $1.26M as of Q2 2026.
  • West Pharmaceutical was a new Dark Forest Capital Management position in Q2 2026.
  • West Pharmaceutical made up 0.08% of Dark Forest Capital Management's portfolio in Q2 2026, its #436 holding.
  • Dark Forest Capital Management first reported a position in West Pharmaceutical in Q2 2021 and has held it in 9 quarters since.
  • Dark Forest Capital Management's West Pharmaceutical position peaked at $5.54M in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.